Cell & Gene: The Podcast
Cell & Gene: The Podcast
Identifying Drug Development Opportunities for DMD with CureDuchenne
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
We love to hear from our listeners. Send us a message.
Debra Miller, CEO and Founder and Dr. Michael Kelly, Chief Scientific Officer at CureDuchenne talk to Host Erin Harris about the FDA approval for the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics as well as how CureDuchenne works with various biotechs developing gene therapies for Duchenne muscular dystrophy (DMD). Miller and Kelly also share their advice and recommendations for companies developing drugs for DMD - while much progress has been made, more innovation is needed.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.